recurrent nasal cavity and paranasal sinus squamous cell carcinoma

Showing 1 - 4 of 4

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Head and Neck Squamous Cell Carcinoma, Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Recurrent Nasopharynx

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +14 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 11, 2022

Recurrent Colon Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma Trial

Completed
  • Recurrent Colon Carcinoma
  • +41 more
  • Cetuximab
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Mar 12, 2020

Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma, Recurrent Laryngeal Verrucous

Completed
  • Recurrent Hypopharyngeal Squamous Cell Carcinoma
  • +35 more
  • Cetuximab
  • +2 more
  • Scottsdale, Arizona
  • +23 more
Feb 23, 2017

Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma, Recurrent Laryngeal Verrucous

Completed
  • Recurrent Hypopharyngeal Squamous Cell Carcinoma
  • +22 more
  • Cediranib Maleate
  • Laboratory Biomarker Analysis
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Apr 14, 2015